5th Transgenic Technology Meeting (http://www.imbim.uu.se/transtech) by Montoliu, Lluís
5th Transgenic Technology Meeting 
(http://www.imbim.uu.se/transtech) 
 
The 5th meeting on Transgenic Technologies 
took place in Uppsala (Sweden) on March 14-
16, 2004, organized by Karin Nilsson 
(Transgenic Facility at Uppsala University), 
Johannes Wilbertz (Karolinska Center for 
Transgene Technologies, Karolinska Institutet, 
Stockholm) and Nelson Khoo (Transgenic 
Facility at Umeå University). This is the fifth 
meeting opportunity for scientists, technicians, 
students and commercial exhibitors to meet 
and discuss different aspects of genetic 
modification of animals. These meetings 
originated in 1998, thanks to the pioneering 
initiative of Johannes Wilbertz who brought 
together a range of important topics which are 
not usually addressed in other mouse meetings. 
That Scandinavian initiative was very well 
received by the mouse-community, readily 
becoming first a European and then finally 
evolving into one of the key International 
meetings where all professionals interested in 
the production of transgenic animals can meet 
and openly discuss new methods, their specific 
problems, offer solutions and propose 
imaginative strategies for the future. The 
uniqueness focus of a balanced combination of 
excellent scientific presentations and most 
valuable technical discussions, are interesting 
both to scientists responsible for the analysis of 
newly created animal models and qualified 
technicians directly engaged in the generation 
of transgenic animals. 
 
The meeting in Uppsala started with two 
presentations on transgenic animals and the 
environment. Graham Tobin (Harlan, UK) 
discussed the effect of phyto-oestrogens, 
commonly found in animal diets, and their 
undesirable influence on animal reproductive 
aspects. Kembra Howdeshell (Univ. Michigan, 
USA) called the attention of the audience to 
Bisphenol A release from commonly used 
polycarbonate animal cages and its unwanted 
effects in animal production. 
Next, the third genOway prize for Transgenic 
technologies for outstanding contributions in 
the field of transgenic research (sponsored by 
this French biotech company), was awarded to 
Qi Zhou (Inst. Zoology, Chinese Acad. 
Sciences, Beijing, China) for his work leading 
to the first rat generated by nuclear transfer.  
 
A session devoted to animal facility planning 
followed, where three different examples 
(AstraZeneca, Södertälje, Sweden; NCI, 
Amsterdam, The Netherlands; Göteborg 
University, Sweden) were presented, 
illustrating the problems encountered and the 
solutions implemented. The impact of new 
technologies in the generation of transgenic 
mice was also the subject of a session, where 
new electroporation methods (Amaxa 
biosystems, Köln, Germany), chemical 
mutagenesis of mouse genome (Ingenium 
Pharmaceuticals, Martinsried, Germany), 
methods to speed up conditional gene targeting 
(Artemis Pharmaceuticals, Köln, Germany) 
and advances in viral and RNAi technologies 
(BD Biosciences Clontech) were discussed. 
There was also a presentation about the 
EMMA (European Mouse Mutant Archive) 
project, from the Swedish partner of this 
European initiative. 
 
On the second day, discussions focused around 
the in vitro differentiation of ES cells as a tool 
for addressing the role of genes involved in 
embryo-lethal phenotypes. Jürgen Rhowedel 
(Univ. Lübeck) presented the topic in depth 
and Meng Li (Univ. Edimburgh) took over and 
elaborated a presentation on in vitro ES cell-
derived dopaminergic neurons. The session 
closed with two presentations on 
hematopoietic and vascular differentiation 
from ES cells, by Leif Carlsson (Univ. Umeå) 
and Lena Claesson-Welsh (Univ. Uppsala), 
respectively. 
 
The meeting finished with a session on 
transgenic models for biomedical research, 
where Helena Edlund (Univ. Umeå) described 
mouse models to study pancreas development 
and beta cell function and Freddy Radtke 
(Ludwig Inst. for Cancer Research, Epalinges, 
Switzerland) described some of the known 
pleiotropic functions of Notch1 using animal 
models. 
 
The next Trans-Tech meeting is scheduled for 
September 2005 and will take place in Spain 
(http://www.cnb.uam.es/~tt2005/). I will have 
the responsibility and the pleasure to organize 
the meeting, with the help of colleagues in our 
country. Therefore, for the first time, a 
transgenic technology meeting will go South 
where it is expected that warmer weather will 
maintain and hopefully encourage the friendly, 
helpful and useful atmosphere that has been 
present to date in this unique type of forum.  
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